Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 215

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

The effect of spike mutations on SARS-CoV-2 neutralization

Open access
Rees-Spear, Chloe, Muir, Luke, Griffith, Sarah A., Heaney, Judith, Aldon, Yoann, Snitselaar, Jonne L., Thomas, Peter, Graham, Carl, Seow, Jeffrey, Lee, Nayung, Rosa, Annachiara, Roustan, Chloe, Houlihan, Catherine F., Sanders, Rogier W., Gupta, Ravindra K., Cherepanov, Peter, Stauss, Hans J., Nastouli, Eleni, Doores, Katie J., van Gils, Marit J., McCoy, Laura E. · 2021 · Cell Reports

Abstract

Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines show protective efficacy, which is most likely mediated by neutralizing antibodies recognizing the viral entry protein, spike. Because new SARS-CoV-2 variants are emerging rapidly, as exemplified by the B.1.1.7, B.1.351, and P.1 lineages, it is critical to understand whether antibody responses induced by infection with the original SARS-CoV-2 virus or current vaccines remain effective. In this study, we evaluate neutralization of a series of mutated spike pseudotypes based on divergence from SARS-CoV and then compare neutralization of the B.1.1.7 spike pseudotype and individual mutations. Spike-specific monoclonal antibody neutralization is reduced dramatically; in contrast, polyclonal antibodies from individuals infected in early 2020 remain active against most mutated spike pseudotypes, but potency is reduced in a minority of samples. This work highlights that changes in SARS-CoV-2 spike can alter neutralization sensitivity and underlines the need for effective real-time monitoring of emerging mutations and their effect on vaccine efficacy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2021.108890

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 23

  1. Burton, 2012, Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses, Science, 337, 183, 10.1126/science.1225416 · DOI · Paper page
  2. Cao, 2020, Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells, Cell, 182, 73, 10.1016/j.cell.2020.05.025 · DOI · Paper page
  3. 2003, Update: Outbreak of severe acute respiratory syndrome--worldwide, 2003, MMWR Morb. Mortal. Wkly. Rep., 52, 241
  4. Cevik, 2020, Virology, transmission, and pathogenesis of SARS-CoV-2, BMJ, 371, m3862, 10.1136/bmj.m3862 · DOI · Paper page
  5. Collier, 2021, SARS-CoV-2 B.1.1.7 escape from mRNA vaccine-elicited neutralizing antibodies, medRxiv
  6. Hu, 2021, Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies, bioRxiv
  7. Lipsitch, 2003, Transmission dynamics and control of severe acute respiratory syndrome, Science, 300, 1966, 10.1126/science.1086616 · DOI · Paper page
  8. Liu, 2020, Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity, Immunity, 53, 1272, 10.1016/j.immuni.2020.10.023 · DOI · Paper page
  9. Mor, 2020, Multi-Clonal Live SARS-CoV-2 In Vitro Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors, bioRxiv
  10. O’Nions, 2021, SARS-CoV-2 antibody responses in patients with acute leukaemia, Leukemia, 35, 289, 10.1038/s41375-020-01103-2 · DOI
  11. Ortega, 2020, Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis, EXCLI J., 19, 410
  12. Oude Munnink, 2021, Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans, Science, 371, 172, 10.1126/science.abe5901 · DOI · Paper page
  13. Petersen, 2020, Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics, Lancet Infect. Dis., 20, e238, 10.1016/S1473-3099(20)30484-9 · DOI · Paper page
  14. Pettersen, 2004, UCSF Chimera--a visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084 · DOI · Paper page
  15. Rosa, 2021, SARS-CoV-2 recruits a haem metabolite to evade antibody immunity, medRxiv
  16. Shen, 2021, SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines, bioRxiv
  17. Varabyou, 2020, Rapid detection of inter-clade recombination in SARS-CoV-2 with Bolotie, bioRxiv
  18. Welkers, 2021, Possible host-adaptation of SARS-CoV-2 due to improved ACE2 receptor binding in mink, Virus Evol, 7, veaa094, 10.1093/ve/veaa094 · DOI
  19. Wu, 2020, A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody, PLoS Pathog., 16, e1009089, 10.1371/journal.ppat.1009089 · DOI
  20. Wu, 2021, mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants, bioRxiv
  21. Xu, 2021, Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM, Sci. Adv., 7, eabe5575, 10.1126/sciadv.abe5575 · DOI · Paper page
  22. Yi, 2020, Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies, Cell. Mol. Immunol., 17, 621, 10.1038/s41423-020-0458-z · DOI · Paper page
  23. Zost, 2019, Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens, J. Infect. Dis., 219, S38, 10.1093/infdis/jiy696 · DOI

Cited by

See all 215

Metadata

Authors
Rees-Spear, C., Muir, L., Griffith, S. A., Heaney, J., Aldon, Y., Snitselaar, J. L., Thomas, P., Graham, C., Seow, J., Lee, N., Rosa, A., Roustan, C., Houlihan, C. F., Sanders, R. W., Gupta, R. K., Cherepanov, P., Stauss, H. J., Nastouli, E., Doores, K. J., van Gils, M. J., & McCoy, L. E.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2021-03
Volume
34
Issue
12
Pages
108890
ISSN
2211-1247 (ISSN-L)
OpenAlex
W3135556657
Cited by
215
References
35
FWCI
15.92
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • Bill and Melinda Gates Foundation (INV-002022)
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Wellcome Trust
  • UCLH Biomedical Research Centre
  • Francis Crick Institute (FC001061)
  • Royal Free Hospital
  • Medical Research Council (MR/R008698/1, MC_PC_19082)
  • National Institutes of Health (P01 AI110657)
  • Cancer Research UK

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.